Jyothy Laboratories Ltd.
Post acquisition, Jyothy Laboratories Ltd (JLL) has demonstrated
impeccable growth with Revenues, EBITDA & PAT witnessing 10.9%, 21.3% and 29.2% CAGR growth respectively. Along with strong performance debt has seen substantial reduction with return ratios climbing. The market too has re-rated the stock reflected in the buoyant prices. While the stock is not cheap we still believe that going forth the robust growth should continue.
For better investment contact
KKP CAPITAL, 9894333189
Stocksandshareanalyst @ https://bit.ly/2JHOzJ
Share Broker In Dindigul